Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Oliver Van Oekelen"'
Autor:
Adolfo Aleman, Morgan van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Christian Cognigni, Jacob Mischka, Lucia Y. Chen, Bhaskar Upadhyaya, Kseniya Serebryakova, Jessica R. Nardulli, Neko Lyttle, Katerina Kappes, Hayley Jackson, Charles R. Gleason, Annika Oostenink, Gianna Y. Cai, Oliver Van Oekelen, Harm van Bakel, Emilia Mia Sordillo, Carlos Cordon-Cardo, Miriam Merad, Sundar Jagannath, Ania Wajnberg, Viviana Simon, Samir Parekh, Hala Alshammary, Dalles Andre, Radhika Banu, Katherine Beach, María Carolina Bermúdez-González, Ajai Chari, Yuexing Chen, Hearn Cho, Adolfo Firpo, Ana Silvia Gonzalez-Reiche, Eun Hye Kim, Giulio Kleiner, Florian Krammer, Jacob Mauldin, Rao Mendu, Brian Monahan, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adrianna Rossi, Ashley Salimbangon, Laryssa Sanchez, Daniel Verina
Publikováno v:
EBioMedicine, Vol 98, Iss , Pp 104886- (2023)
Summary: Background: The real-world impact of bivalent vaccines for wild type (WA.1) and Omicron variant (BA.5) is largely unknown in immunocompromised patients with Multiple Myeloma (MM). We characterize the humoral and cellular immune responses in
Externí odkaz:
https://doaj.org/article/cc58fda45a4f4326af1b2763e037bc22
Autor:
Oliver Van Oekelen, Nicole Birrer, William Wesson, Vincent L. Galate, Edward R. Scheffer Cliff, Aaron M. Goodman, Al-Ola Abdallah, Rajshekhar Chakraborty, Vinay Prasad, Ghulam Rehman Mohyuddin
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/61a6cc8b32914c95ae3ea1eab52fca80
Autor:
Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine, Diane Marie Del Valle, Joshua Richter, Hearn Jay Cho, Shambavi Richard, Ajai Chari, Sacha Gnjatic, Miriam Merad, Sundar Jagannath, Samir Parekh, Deepu Madduri
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-12 (2020)
Abstract Background The COVID-19 pandemic, caused by SARS-CoV-2 virus, has resulted in over 100,000 deaths in the USA. Our institution has treated over 2000 COVID-19 patients during the pandemic in New York City. The pandemic directly impacted cancer
Externí odkaz:
https://doaj.org/article/2a8a134dee804d76a7bfadb029e72a2b
Autor:
Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff, Jeanne Li, Yogita Ghodke-Puranik, Guido Lancman, Santiago Thibaud, Darren Pan, Sridevi Rajeeve, Sarita Agte, Adolfo Aleman, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez, Alessandro Lagana, Erin Moshier, Ajai Chari, Sundar Jagannath, Samir Parekh
Publikováno v:
Blood Advances. 7:1056-1064
T-cell redirection therapy using chimeric antigen receptor (CAR) T cells and bispecific antibodies (BiAbs) has shown promising efficacy in heavily pretreated patients with relapsed/refractory multiple myeloma (RRMM), leading to the approval of 2 CAR
Autor:
Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T. Melnekoff, Yogita Ghodke-Puranik, Gunjan L. Shah, Alexander Lesokhin, Sergio Giralt, Santiago Thibaud, Adriana Rossi, Cesar Rodriguez, Larysa Sanchez, Joshua Richter, Shambavi Richard, Hearn J. Cho, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Urvi A. Shah, Sham Mailankody, Samir Parekh
Publikováno v:
Blood. 141:756-765
B-cell maturation antigen (BCMA)–directed chimeric antigen receptor T-cell (CAR T) therapy has demonstrated remarkable efficacy in patients with relapsed/refractory multiple myeloma, and now there are two US Food and Drug Administration–approved
Autor:
Ghulam Rehman Mohyuddin, Jennifer M Ahlstrom, Cindy A Chmielewski, Nathan W Sweeney, Thomas H Molina, Christian S Cheung, Emily Watabe Ballard, Felicia F Seng, Oliver Van Oekelen, Amandeep Godara, Brian McClune, Douglas Sborov
Publikováno v:
The Lancet Haematology. 9:e716-e719
Autor:
Adolfo Aleman, Ariel Kogan Zajdman, Yogita Ghodke-Puranik, Bhaskar Upadhyaya, Tarek H. Mouhieddine, Oliver Van Oekelen, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn J. Cho, Cesar Rodriguez, Ajai Chari, Sundar Jagannath, Samir Parekh
Publikováno v:
Blood. 140:4193-4195
Autor:
Santiago Thibaud, Md. Babu Mia, Oliver Van Oekelen, Tarek H. Mouhieddine, Christoph Schaniel, Yogita Ghodke-Puranik, Adolfo Aleman, Bhaskar Upadhyaya, Guido Lancman, Alessandro Lagana, Shambavi Richard, Adriana Rossi, Ajai Chari, Larysa Sanchez, Cesar Rodriguez, Hearn J. Cho, Joshua Richter, Ronald Hoffman, Sundar Jagannath, Samir Parekh
Publikováno v:
Blood. 140:614-616
Autor:
Anjan Thakurta, Amit Agarwal, Samir Parekh, Natalya Serbina, Weiyuan Chung, Mary Young, Paola Neri, Oliver Van Oekelen, Adeeb Rahman, David S. Siegel, Nizar J. Bahlis, Michael D. Amatangelo, William E. Pierceall
Supplementary Methods and Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb48aff86ac037000be34cec7335e0b
https://doi.org/10.1158/1078-0432.22476230
https://doi.org/10.1158/1078-0432.22476230
Autor:
Anjan Thakurta, Amit Agarwal, Samir Parekh, Natalya Serbina, Weiyuan Chung, Mary Young, Paola Neri, Oliver Van Oekelen, Adeeb Rahman, David S. Siegel, Nizar J. Bahlis, Michael D. Amatangelo, William E. Pierceall
Purpose:Addition of daratumumab to pomalidomide and low-dose dexamethasone (LoDEX) is a safe and effective combination for relapsed/refractory multiple myeloma treatment. We sought to better understand immune combinational benefit of pomalidomide and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::541b9351dca923216603686db434ef6b
https://doi.org/10.1158/1078-0432.c.6529340
https://doi.org/10.1158/1078-0432.c.6529340